论文信息 - Efficacy and safety of everolimus plus exemestane in patients with HR+, HER2− advanced breast cancer progressing on/after prior endocrine therapy in routine clinical practice: Primary results from the non-interventional study, STEPAUT - 字舞流文

Efficacy and safety of everolimus plus exemestane in patients with HR+, HER2− advanced breast cancer progressing on/after prior endocrine therapy in routine clinical practice: Primary results from the non-interventional study, STEPAUT

R. Greil | M. Gnant | G. Steger | C. Marth | A. Redl | E. Petru | R. Bartsch | G. Pfeiler | D. Egle | F. Haslbauer | M. Hubalek | K. Hock | C. Tinchon | R. Helfgott | L. Öhler | B. Mraz | A. Lang | M. Hennebelle